Selection, design, and engineering of therapeutic antibodies
- 1 October 2005
- journal article
- review article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 116 (4) , 731-736
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Design of humanized antibodies: From anti-Tac to ZenapaxMethods, 2005
- The therapeutic antibodies market to 2008European Journal of Pharmaceutics and Biopharmaceutics, 2005
- Differential expression of mucins 1–6 in papillary thyroid carcinoma: evidence for transformation‐dependent post‐translational modifications of MUC1 in situThe Journal of Pathology, 2003
- Genetic engineering of an immunotoxin to eliminate pulmonary vascular leak in miceNature Biotechnology, 2003
- Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular ToxicityJournal of Biological Chemistry, 2002
- Structure of the Human IgE-Fc Cε3-Cε4 Reveals Conformational Flexibility in the Antibody Effector DomainsImmunity, 2000
- Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides 1 1Edited by I. A. WilsonJournal of Molecular Biology, 2000
- Human Antibodies with Sub-nanomolar Affinities Isolated from a Large Non-immunized Phage Display LibraryNature Biotechnology, 1996
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987
- Replacing the complementarity-determining regions in a human antibody with those from a mouseNature, 1986